Skip to main content
Signal8

Stemtech Corp (STEK) Form 10-Q — Jun 22, 2026

$STEKForm 10-QFiled Jun 22, 2026, 4:33 PM ET0001683168-26-005028Original filing

Stemtech Corp reported a net loss of $1.25 million for the quarter ended March 31, 2026, an improvement from the $1.46 million loss in the prior-year period, driven by expense reductions. Net sales fell 47% year-over-year to $462,957, primarily due to inventory constraints that limited the company's ability to fulfill distributor orders. The company’s financial position remains precarious with a working capital deficit of $10.5 million and cash on hand of $256,149. Management explicitly raised substantial doubt about the company’s ability to continue as a going concern, stating it requires additional capital to fund operations and cannot assure financing will be available.

Key figures

Eps
0
Revenue
462957
Total Debt
4159460
Revenue Yoy
-46.7%
Cash Position
256149
Shares Outstanding
1649816690
Gross margin
76.4%
Gross profit
353653
Working capital deficit
10461764

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.